IBMCP startups
The Institute for Plant Molecular and Cellular Biology (IBMCP) has fostered the creation of several spin-offs that bring academic research into the productive sector.
Among them is MadeInPlant, founded in 2021, which focuses on the production of high-value biomolecules and the development of biotechnological tools for agriculture.
Another example is NAPLAtec, dedicated to plant-based platforms for the production of carotenoids aimed at the nutraceutical and pharmaceutical sectors.
In addition, FL70, Inc., in collaboration with IBMCP, combines molecular and plant biology to develop new technologies for combating plant pests and diseases through RNA-based gene therapies.
MadeInPlant is a spin-off, established at the end of 2021, that arises as a result of the joint research of three IBMCP groups. MadeInPlant is an agri-biotechnology company that currently has two differentiated lines of business.
The first one is dedicated to the production in plants of high value-added biomolecules for various sectors such as the cosmetic, pharmaceutical, scientific-technological, or food industries.
The second focuses on the development of biotechnological tools to address specific needs in the agricultural sector in processes like genetic improvement or pathogen identification.
It is currently in a seed phase, in the process of defining and executing its business plan.
NAPLATEC is a spin-off from the University of Castilla-La Mancha, newly created and dedicated to research and patent exploitation. It includes scientists from Albacete (UCLM) and Valencia (IBMCP-UPV-CSIC).
Its activity focuses on developing new plant biological platforms for the hyperproduction of carotenoids, especially crocins, for use in the nutraceutical, cosmetic, pharmaceutical, and agri-food sectors.
FL70, Inc is one of the latest companies founded by the venture capital fund Flagship Pioneering in collaboration with IBMCP scientists. This fund is responsible for the creation of companies such as Moderna Therapeutics, Rubius Therapeutics, and Evelo Therapeutics.
FL70 integrates the latest developments in molecular and plant biology to generate a new technological platform for combating plant pests and diseases through RNA-based gene therapies.
